CA2225628C - Composition pharmaceutique administrable par voie orale a liberation differee d'un ingredient actif d'inhibiteurs reversibles de la pompe a protons - Google Patents

Composition pharmaceutique administrable par voie orale a liberation differee d'un ingredient actif d'inhibiteurs reversibles de la pompe a protons Download PDF

Info

Publication number
CA2225628C
CA2225628C CA002225628A CA2225628A CA2225628C CA 2225628 C CA2225628 C CA 2225628C CA 002225628 A CA002225628 A CA 002225628A CA 2225628 A CA2225628 A CA 2225628A CA 2225628 C CA2225628 C CA 2225628C
Authority
CA
Canada
Prior art keywords
pyridine
proton pump
pump inhibitor
reversible proton
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002225628A
Other languages
English (en)
Other versions
CA2225628A1 (fr
Inventor
Rango Dietrich
George Sachs
Stefan Postius
Hartmut Ney
Jorg Senn-Bilfinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/498,391 external-priority patent/US6132768A/en
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of CA2225628A1 publication Critical patent/CA2225628A1/fr
Application granted granted Critical
Publication of CA2225628C publication Critical patent/CA2225628C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
CA002225628A 1995-07-05 1996-07-02 Composition pharmaceutique administrable par voie orale a liberation differee d'un ingredient actif d'inhibiteurs reversibles de la pompe a protons Expired - Fee Related CA2225628C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/498,391 1995-07-05
US08/498,391 US6132768A (en) 1995-07-05 1995-07-05 Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
PCT/EP1996/002893 WO1997002021A1 (fr) 1995-07-05 1996-07-02 Composition pharmaceutique administrable par voie orale a liberation differee d'un ingredient actif d'inhibiteurs reversibles de la pompe a protons

Publications (2)

Publication Number Publication Date
CA2225628A1 CA2225628A1 (fr) 1997-01-23
CA2225628C true CA2225628C (fr) 2007-01-02

Family

ID=37603476

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002225628A Expired - Fee Related CA2225628C (fr) 1995-07-05 1996-07-02 Composition pharmaceutique administrable par voie orale a liberation differee d'un ingredient actif d'inhibiteurs reversibles de la pompe a protons

Country Status (1)

Country Link
CA (1) CA2225628C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9607182B1 (en) 2016-02-02 2017-03-28 International Business Machines Corporation Universal emergency power-off switch security device

Also Published As

Publication number Publication date
CA2225628A1 (fr) 1997-01-23

Similar Documents

Publication Publication Date Title
EP0841904B1 (fr) Composition pharmaceutique administrable par voie orale a liberation differee d'un ingredient actif d'inhibiteurs reversibles de la pompe a protons
CA2232450C (fr) Composition pharmaceutique administrable par voie orale contenant des agents actifs antimicrobiens et du pantoprazole a liberation differee
CA2186039C (fr) Nouvelle forme galenique pharmaceutique orale
EP1746980B1 (fr) Forme pharmaceutique comprenant des pellets et procédé de fabrication
MXPA05001538A (es) Distribuidor de tipo manguito de endoscopio.
CZ283684B6 (cs) Pulzní systémy pro podávání minocyklinu jednou denně
MXPA96004354A (en) New form of pharmaceutical dosage or
WO2011104275A1 (fr) Préparations pour une administration par voie orale libérant des adsorbants dans l'intestin
AU2010200905A1 (en) Dosage form containing pantoprazole as active ingredient
US20080050428A1 (en) Oral Pharmaceutical Preparation Comprising a Proton Pump Antagonist and a Basic Excipient
CA2290824A1 (fr) Composition pharmaceutique contenant du benzimidazole et procede de preparation
CA2225628C (fr) Composition pharmaceutique administrable par voie orale a liberation differee d'un ingredient actif d'inhibiteurs reversibles de la pompe a protons
US20120164233A1 (en) Pulsatile release pharmaceutical formulation of dexlansoprazole
JP2020073583A (ja) ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形
US20060204568A1 (en) Oral pharmaceutical preparation for proton pump antagonists
MXPA05001559A (es) Composiciones de mononitrato de isosorbide y metodos de uso de las mismas.
DE10317023A1 (de) Perorale Arzneimittelzubereitung für Protonenpumpenantagonisten
CA2563162C (fr) Forme posologique contenant du pantoprazole en tant qu'ingredient actif
WO2009105023A1 (fr) Formulation pharmaceutique comprenant des oxabispidines/236

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed